Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis

Journal of Cell Science

Volumn 125, Issue 9, 2012, Pages 2267-2275

  Mascall, Keith S ^a   Small, Gary R ^a,b   Gibson, George ^a   Nixon, Graeme F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Angiogenesis; Metalloproteinase; Sphingosine 1 phosphate; Vascular smooth muscle

Indexed keywords

RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL JUNCTION; CONTROLLED STUDY; CORONARY ARTERY; EX VIVO STUDY; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADHERENS JUNCTIONS; CELL COMMUNICATION; COCULTURE TECHNIQUES; CORONARY VESSELS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; LYSOPHOSPHOLIPIDS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RHO-ASSOCIATED KINASES; SPHINGOSINE; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84862900129     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.099044     Document Type: Article

References (47)

1. Argraves, K. M., Wilkerson, B. A. and Argraves, W. S. (2010). S1P signalling in vasculogenesis and angiogenesis. World J. Biol. Chem. 1, 291-297.
2. Bayless, K. J. and Davis, G. E. (2003). Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem. Biophys. Res. Commun. 312, 903-913.
3. Carmeliet, P. and Jain, R. K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307.
4. Carmeliet, P., Lampugnani, M. G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M. et al. (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147-157.
5. Chae, S. S., Paik, J. H., Furneaux, H. and Hla, T. (2004). Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J. Clin. Invest. 114, 1082-1089.
6. Chen, H., Li, D. and Mehta, J. L. (2002). Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 39, 332-339.
7. Coussin, F., Scott, R. H., Wise, A. and Nixon, G. F. (2002). Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ. Res. 91, 151-157.
8. Donovan, D., Brown, N. J., Bishop, E. T. and Lewis, C. E. (2001). Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 4, 113-121.
9. Du, W., Takuwa, N., Yoshioka, K., Okamoto, Y., Gonda, K., Sugihara, K., Fukamizu, A., Asano, M. and Takuwa, Y. (2010). S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Res. 70, 772-781.
10. Fabunmi, R. P., Baker, A. H., Murray, E. J., Booth, R. F. and Newby, A. C. (1996). Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315, 335-342.
11. Feldman, A. L., Stetler-Stevenson, W. G., Costouros, N. G., Knezevic, V., Baibakov, G., Alexander, H. R., Jr, Lorang, D., Hewitt, S. M., Seo, D. W., Miller, M. S. et al. (2004). Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism. Cancer Res. 64, 4481-4486.
12. Fong, G. H. (2009). Regulation of angiogenesis by oxygen sensing mechanisms. J. Mol. Med. 87, 549-560.
13. Fukushima, M., Nakamuta, M., Kohjima, M., Kotoh, K., Enjoji, M., Kobayashi, N. and Nawata, H. (2005). Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int. 25, 829-838.
14. Hawkes, S. P., Li, H. and Taniguchi, G. T. (2001). Zymography and reverse zymography for detecting MMPs, and TIMPs. Methods Mol. Biol. 151, 399-410.
15. Hunter, I. and Nixon, G. F. (2006). Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-a-mediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways. J. Biol. Chem. 281, 34705-34715.
16. Inoki, I., Takuwa, N., Sugimoto, N., Yoshioka, K., Takata, S., Kaneko, S. and Takuwa, Y. (2006). Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor. Biochem. Biophys. Res. Commun. 346, 293-300.
17. Kandalam, V., Basu, R., Abraham, T., Wang, X., Soloway, P. D., Jaworski, D. M., Oudit, G. Y. and Kassiri, Z. (2010). TIMP2 deficiency accelerates adverse postmyocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ. Res. 106, 796-808.
18. Kluk, M. J. and Hla, T. (2001). Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ. Res. 89, 496-502.
19. LaMontagne, K., Littlewood-Evans, A., Schnell, C., O'Reilly, T., Wyder, L., Sanchez, T., Probst, B., Butler, J., Wood, A., Liau, G. et al. (2006). Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res. 66, 221-231.
20. Lee, M. J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I. and Hla, T. (1999). Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99, 301-312.
21. Lucke, S. and Levkau, B. (2010). Endothelial functions of sphingosine-1-phosphate. Cell. Physiol. Biochem. 26, 87-96.
22. Meyer zu Heringdorf, D. and Jakobs, K. H. (2007). Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta 1768, 923-940.
23. Murata, N., Sato, K., Kon, J., Tomura, H. and Okajima, F. (2000). Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. Anal. Biochem. 282, 115-120.
24. Murphy, A. N., Unsworth, E. J. and Stetler-Stevenson, W. G. (1993). Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157, 351-358.
25. Nicosia, R. F. (2009). The aortic ring model of angiogenesis: a quarter century of search and discovery. J. Cell. Mol. Med. 13, 4113-4136.
26. Oyama, O., Sugimoto, N., Qi, X., Takuwa, N., Mizugishi, K., Koizumi, J. and Takuwa, Y. (2008). The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice. Cardiovasc. Res. 78, 301-307.
27. Peters, S. L. and Alewijnse, A. E. (2007). Sphingosine-1-phosphate signaling in the cardiovascular system. Curr. Opin. Pharmacol. 7, 186-192.
28. Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G. and Brown, S. (2009). Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem. 78, 743-768.
29. Sanchez, T. and Hla, T. (2004). Structural and functional characteristics of S1P receptors. J. Cell. Biochem. 92, 913-922.
30. Saunders, W. B., Bohnsack, B. L., Faske, J. B., Anthis, N. J., Bayless, K. J., Hirschi, K. K. and Davis, G. E. (2006). Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J. Cell Biol. 175, 179-191.
31. Schmid, G., Guba, M., Ischenko, I., Papyan, A., Joka, M., Schrepfer, S., Bruns, C. J., Jauch, K. W., Heeschen, C. and Graeb, C. (2007). The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. J. Cell. Biochem. 101, 259-270.
32. Seo, D. W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B. Y. and Stetler-Stevenson, W. G. (2003). TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 114, 171-180.
33. Skoura, A., Sanchez, T., Claffey, K., Mandala, S. M., Proia, R. L. and Hla, T. (2007). Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J. Clin. Invest. 117, 2506-2516.
34. Small, G. R., Hadoke, P. W., Sharif, I., Dover, A. R., Armour, D., Kenyon, C. J., Gray, G. A. and Walker, B. R. (2005). Preventing local regeneration of glucocorticoids by 11b-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc. Natl. Acad. Sci. USA 102, 12165-12170.
35. Stetler-Stevenson, W. G. and Seo, D. W. (2005). TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol. Med. 11, 97-103.
36. Sun, X., Shikata, Y., Wang, L., Ohmori, K., Watanabe, N., Wada, J., Shikata, K., Birukov, K. G., Makino, H., Jacobson, J. R. et al. (2009). Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. Microvasc. Res. 77, 304-313.
37. Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G. and Albini, A. (1998). TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246-253.
38. van der Laan, A. M., Piek, J. J. and van Royen, N. (2009). Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat. Rev. Cardiol. 6, 515-523.
39. Vestweber, D. (2008). VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 28, 223-232.
40. Wang, L. and Dudek, S. M. (2009). Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc. Res. 77, 39-45.
41. Wang, Y., Kaiser, M. S., Larson, J. D., Nasevicius, A., Clark, K. J., Wadman, S. A., Roberg-Perez, S. E., Ekker, S. C., Hackett, P. B., McGrail, M. et al. (2010). Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis. Development 137, 3119-3128.
42. Wang, Z., Juttermann, R. and Soloway, P. D. (2000). TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275, 26411-26415.
43. Webb, C. S., Bonnema, D. D., Ahmed, S. H., Leonardi, A. H., McClure, C. D., Clark, L. L., Stroud, R. E., Corn, W. C., Finklea, L., Zile, M. R. et al. (2006). Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114, 1020-1027.
44. Xu, K. and Cleaver, O. (2011). Tubulogenesis during blood vessel formation. Semin. Cell Dev. Biol. 22, 993-1004.
45. Yatomi, Y., Ruan, F., Hakomori, S. and Igarashi, Y. (1995). Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86, 193-202.
46. Yonesu, K., Kawase, Y., Inoue, T., Takagi, N., Tsuchida, J., Takuwa, Y., Kumakura, S. and Nara, F. (2009). Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. Biochem. Pharmacol. 77, 1011-1020.
47. Zachary, I. and Morgan, R. D. (2011). Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 97, 181-189.